FROM AAN 2022 Patients with persistent cognitive impairment months after illness with mild COVID-19 have higher levels of inflammatory markers in their cerebrospinal fluid (CSF). Researchers found elevated levels of CSF immune activation and immunovascular markers in individuals with cognitive postacute sequelae of SARS-CoV-2 infection (PASC). Patients whose cognitive symptoms developed during the acute phase […]
Mar 8
Antibody-Activated Endothelial Cells Increase the Risk of Blood Clots with Covid-19
By: William A. Haseltine Antiphospholipid antibodies activity may help explain hypercoagulation associated with late stages of Covid-19 and long-haul disease. Blood samples from nearly 250 individuals hospitalized for Covid-19 found that these “rouge” antibodies activate endothelial cells, risking widespread blood clots. The activity of antiphospholipid antibodies may help explain hypercoagulation associated with late stages of […]
Mar 8
COVID Patients at Risk for 20 Cardiovascular Diseases
By: Carolyn Crist COVID Patients at Risk for 20 Cardiovascular Diseases March 4, 2022 — People who contract COVID-19 face higher risks for 20 different heart and vascular diseases after being infected, according to a new study published in Nature Medicine. Even people who weren’t hospitalized with COVID-19 developed more cardiovascular disease than those who […]
Mar 8
Opinion: These Covid-19 symptoms raise new questions
With an elevated risk of heart disease, stroke and blood clots as a possible long-term effect of Covid-19, perhaps the Veterans Affairs researchers will do something that almost a million American deaths has not: frighten a broad swath of the vaccine-hesitant into rolling up their sleeves and taking the shots, writes Kent Sepkowitz Two years […]
